FTC Objections To Pharma Mergers Could Go Unchallenged Following Wilson’s Resignation

 
• By Brenda Sandburg

The commission no longer has a voice opposing aggressive antitrust enforcement actions and President Biden's replacement may be more receptive to the stance of the three current Democratic commissioners. Amgen’s proposed acquisition of Horizon is facing FTC scrutiny.

FTC building
FTC Commissioner Christine Wilson's resignation will leave the agency with three Democratic commissioners. • Source: Shutterstock

More from Compliance

More from Pink Sheet